The anti-proliferative effects of a frankincense extract in a window of opportunity phase ia clinical trial for patients with breast cancer.
- 2024-01-09
- Clinical Trial · n = 18
- Breast cancer research and treatment 204(3)
- Ingrid V Bonilla Valente
- Denise Garcia
- Andrea Abbott
- Laura Spruill
- Julie Siegel
- Jessica Forcucci
- George Hanna
- Rupak Mukherjee
- Mark Hamann
- Eleanor Hilliard
- Mark Lockett
- David J Cole
- Nancy Klauber-DeMore
- PubMed: 38194131
- DOI: 10.1007/s10549-023-07215-4
- Moderate evidence
- Clinical
In the B. serrata-treated group there was a reduction in proliferation between core biopsy and excision (n=18) of 13.8 ± 11.7%. This difference was statistically significant between the control and B. serrata-treated groups (p = 0.008).
- Effect
- Beneficial
- Effect size
- Moderate
- Significant
- Yes
- Dose
- 2400 mg/day